Novartis settles with Henrietta Lacks' estate over use of her "stolen" cells to advance medicine [CBS News]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: CBS News
taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine. Details of the agreement, which was finalized in federal court in Maryland this month, aren't public. The Lacks family and Swiss-based Novartis said in a joint statement that they are "pleased they were able to find a way to resolve this matter filed by Henrietta Lacks' Estate outside of court" but aren't commenting further. It's the second settlement in lawsuits filed by the estate that accused biomedical businesses of reaping rewards from a racist medical system that took advantage of Black patients like Lacks. The settlement ends litigation between Novartis, one of the world's largest pharmaceutical companies, and the estate of Lacks, a mother who died of cervical cancer at age 31 and was buried in an unmarked grave. The 2024 lawsuit had sought from Novartis "the full amount of its net profits obtained by commercializing the HeLa cell
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Transformative Biotech Names Mark Kelleher, PhD as Executive VP of R&D [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner [Yahoo! Finance]Yahoo! Finance
- Why Analysts Are Closely Watching Thermo Fisher Scientific Inc. (TMO) [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific Increases Quarterly DividendBusiness Wire
- How Is Thermo Fisher Scientific's Stock Performance Compared to Other Medical Devices Stocks? [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 1/29/26 - Beat
TMO
Sec Filings
- 2/26/26 - Form 10-K
- 2/12/26 - Form 8-K
- 2/11/26 - Form 4
- TMO's page on the SEC website